Nanotechnology Now

Heifer International

Wikipedia Affiliate Button


Home > Press > Microfluidics Introduces Wide Range of Microfluidizer Processors for Pharmaceutical and Biotechnology Industries

Aseptic, Enhanced, and Basic Models Meet Industry-Specific Needs

Microfluidics Introduces Wide Range of Microfluidizer Processors for Pharmaceutical and Biotechnology Industries

NEWTON, MA | Posted on November 22nd, 2008

Microfluidics has introduced a new line of Microfluidizer® high-shear fluid processors designed specifically for the pharmaceutical and biotechnology industries. The comprehensive line of 24 standard pre-engineered models is the widest available on the market and allows companies to meet specific processing requirements of the particular drug being manufactured. The processors are offered in aseptic, enhanced, and basic versions, which are available in various pressure ranges and with two different motor sizes, 25 and 50 hp. All are guaranteed to accurately scale up from lab and pilot-scale Microfluidizer processors, and may be scaled up from other processors as well.

Microfluidizer® processors are used extensively in the pharmaceutical and biotechnology industries to manufacture a wide range of drugs (including cancer therapeutics, vaccines, and anesthetics) delivered through multiple delivery platforms such as injectables, inhalables, parenterals and transdermals. The processors generate a controlled shear rate which allows bacterial, plant, and mammalian cells to be safely and efficiently disrupted. They also impart the highest shear rates of any fluid processor on the market today in order to achieve the desired product quality for nanoemulsions, nanodispersions, liposomes and nano/microencapsulation in the fewest number of passes.

"Microfluidics is excited about offering the widest range of production machines on the market," says Microfluidics' Product Manager, Dave Gucwa. "No other company offers this level of performance and industry specificity. Every company's processing needs are different, and we can now offer variations that suit a wide variety of requirements in such parameters as pressure, temperature control, feed techniques, process monitoring, and FDA 21 CFR part 11 compliant data recordkeeping. Whether the customer is a major producer of injectables or a small startup firm looking to produce clinical batches, Microfluidics has a processor that will make it easier to do the job."

All 24 processors come with the Ultra Clean In Place (UCIP) system, eliminating the need for disassembly for cleaning (COP), as well as written certifications that all product contact surfaces have been ground to a 20Ra surface finish, electro-polished and passivated. In keeping with cGMP guidelines, each processor comes with IQ/OQ documentation, a document turnover package (including material and calibration certificates for validation support), and on-site start-up (and training), and is CE compliant. All processors include a skid-mounted pharma-grade feed pump and a sanitary flush diaphragm pressure transducer.

Designed to provide superior results for pilot and production environments where sterile processing is required—for example, manufacture of injectables, inhalables, and vaccines—the Aseptic BioPharmaceutical Microfluidizer® Processor uses a steam-in- place sanitization step to provide verifiable sterility that always passes the Sterile Fill Test.

The aseptic processor's onboard documentation system includes data recording and transmission that can be fully integrated with the plant's computerized control and monitoring system. The data collection system provides validation support. In addition, the aseptic system's highly secure batch records are 21 CFR part 11 compliant. Aseptic processors come in 10,000 and 20,000 pounds per square inch (psi) models in 25 and 50 hp versions. The 50 hp model is available with synchronous or constant pressure operating styles. Hazardous duty versions are available.

Enhanced BioPharmaceutical Microfluidizer® Processors have instrumentation that is virtually identical to aseptic models, but are designed for manufacturing products that do not require validatable sterility, or those that will use downstream sterile filtration. All instruments and valves are sanitary grade and BPE compliant. Enhanced processors contain the same onboard data recording and physical monitoring system as the aseptic version. Enhanced processors are available in pressure ranges of 10,000, 20,000, or 30,000 psi, in 25 and 50 hp versions. The 50 hp model is available with synchronous or constant pressure operating styles. Hazardous duty versions are available.

Basic BioPharmaceutical Microfluidizer® Processors are designed for economical manufacturing of clinical and production batches. Producers of oral suspensions frequently choose one of the basic processor models. Basic processor models include 10,000, 20,000, or 30,000 psi versions, in 25 or 50 hp versions. The 50 hp model is available with synchronous or constant pressure operating styles. All product paths, instruments, and valves are sanitary grade and BPE compliant. Available upgrade options include pharma-grade heat exchangers, inlet strainer, factory acceptance testing (FAT), site acceptance testing (SAT) with IQ/OQ execution, temperature sensing with digital readouts, and motor starter panels.


About Microfluidics
Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation, is a supplier of advanced fluid-processing equipment and reaction technology for laboratory, pilot-scale and manufacturing applications. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products, and produces the most uniform and smallest liquid and suspended solid particles available.

Microfluidics has been a worldwide supplier of Microfluidizer® high-shear fluid- processing systems to the biotechnology, pharmaceutical, chemical and cosmetics industries since 1984. As a leader in the field, Microfluidics has enabled numerous companies and institutions to formulate, validate and produce licensed drugs for the worldwide healthcare market.

Companies seeking to produce difficult-to-formulate products or to find better methods of bioprocessing can take advantage of complimentary sample testing at any of three Microfluidics facilities.

For more information, please click here

Katie DePorter
Gray & Rice Public Relations
617-367-0100 ext. 121

(800) 370-5452
for application information

Copyright © Microfluidics International Corporation

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Strength in numbers: Researchers develop the first-ever quantum device that detects and corrects its own errors March 4th, 2015

New research could lead to more efficient electrical energy storage March 4th, 2015

Energy-generating cloth could replace batteries in wearable devices March 4th, 2015

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015


Going with the flow January 16th, 2015

How bacteria control their size: By monitoring thousands of individual bacteria scientists discovered how they maintain their size from generation to generation January 6th, 2015

“Line dancing bacteria win the 2014 Dolomite and Lab on a Chip Video Competition” December 16th, 2014

Dolomite launches Mitos Dropix® Droplet Splitting System December 1st, 2014


Experiment and theory unite at last in debate over microbial nanowires: New model and experiments settle debate over metallic-like conductivity of microbial nanowires in bacterium March 4th, 2015

Magnetic vortices in nanodisks reveal information: Researchers from Dresden and Jülich use microwaves to read out information from smallest storage devices March 4th, 2015

CiQUS researchers obtain high-quality perovskites over large areas by a chemical method March 4th, 2015

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015


Keysight Technologies Shifts to Direct Sales of High-Performance Products in North America March 3rd, 2015

Forbidden quantum leaps possible with high-res spectroscopy March 2nd, 2015

International research partnership tricks the light fantastic March 2nd, 2015

Important step towards quantum computing: Metals at atomic scale March 2nd, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE